Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Sponsored by GT Medical Technologies, Inc.
About this trial
Last updated 2 years ago
Study ID
Status
Type
Placebo
Accepting
Not accepting
Trial Timing
Started 5 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
1. Patients who undergo maximum safe resection of intracranial neoplasm(s) AND implantation of GammaTiles.
2. Willing and able to provide informed consent and to participate in all evaluations.
Exclusion Criteria
1. Inability to undergo pre-operative and post-operative imaging for disease and implant assessment.
2. Major medical or psychiatric illness, which, in the investigator's opinion would prevent completion of treatment, ability to complete assessments at the time of enrollment, and/or interfere with follow ups.
3. Lack of English language fluency sufficient to allow for completion of neurocognitive and QOL tests (which are in English).